Rj. Dewinter et al., VALUE OF MYOGLOBIN, TROPONIN-T, AND CK-MB(MASS) IN RULING OUT AN ACUTE MYOCARDIAL-INFARCTION IN THE EMERGENCY ROOM, Circulation, 92(12), 1995, pp. 3401-3407
Background Ruling out acute myocardial infarction (AMI) on the basis o
f rapid assays for cardiac markers will allow early triage of patients
and cost-effective use of available coronary care facilities. Methods
and Results We studied the value of myoglobin, creatine kinase (CK)-M
B(mass) and troponin T in ruling out an AMI in the emergency room in 3
09 consecutive patients presenting with chest pain. The gold standard
for AMI was the combination of history, EGG, and a typical curve of th
e CK-MB activity (CK-MB(act)). Myoglobin was the earliest marker, and
its negative predictive value (NPV) was significantly higher than for
CK-MB(mass) and troponin T from 3 to 6 hours after the onset of sympto
ms (myoglobin versus CKMB(mass) P<.03; myoglobin versus troponin T, P<
.01). The NPV of myoglobin reached 89% 4 hours after the onset of symp
toms. The NPV of CK-MB(mass) reached 95% 7 hours after the onset of sy
mptoms. Troponin T was not an early marker for ruling out AMI, and NPV
changed over time, together with CK-MB(act). The early NPV was higher
in a subgroup of patients with a low probability of the presence of A
MI for the three markers. Cardiac markers rise earlier in patients wit
h large infarcts than in patients with small infarcts as indicated by
the cumulative proportion of the marker above the upper reference limi
t at each time point (myoglobin, P=.04; CK-MB(mass), P=.013; troponin
T, P=.016). Conclusions For ruling out AMI in the emergency room, myog
lobin is a better marker than CK-MB(mass) or troponin T from 3 until 6
hours after the onset of symptoms, but the maximal NPV reaches only 8
9%. At 7 hours, the NPV of CK-MB(mass) is 95%. The test characteristic
s are influenced by the probability of the presence of AMI in the pati
ents studied and by the size of their AMI. Infarct size of AMI patient
s should be reported in studies evaluating cardiac markers.